About this trial
Endovascular treatment tends to replace open surgery in the management of peripheral arterial disease. Access via the common femoral artery remains the primary approach for peripheral arterial interventions. Brachial artery access has emerged as a valid alternative when femoral access is not feasible. Brachial access can be achieved either percutaneously or through an open surgical approach at the elbow.
A limited number of studies have reported complication rates associated with open and percutaneous brachial access in the treatment of peripheral arterial disease. These studies have shown higher complication rates for percutaneous access (ranging from 6% to 9%) compared with open brachial access (ranging from 1% to 2%). However, no direct comparison between the two approaches has been reported to date.
This study is the first to provide a direct, prospective, randomized comparison between open brachial access and percutaneous brachial access
Eligibility criteria
Qualifiers
Age ≥ 18 years
Endovascular diagnostic or therapeutic procedure via the brachial approach compatible with a 5F to 7F introducer
Patient affiliated with a social security scheme
Disqualifiers
Adult patient under legal guardianship or curatorship
Contraindication to endovascular treatment
History of brachial artery puncture within the past 1 month
History of open surgical approach at the elbow
Trial design
Treatments tested in this trial
- Experimental arm
- Procedure/Standard care